Literature DB >> 18815394

Storm over statins--the controversy surrounding pharmacologic treatment of children.

Sarah de Ferranti1, David S Ludwig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815394     DOI: 10.1056/NEJMp0805953

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

Review 1.  Cholesterol screening and statin use in children: a literature review.

Authors:  Karen King; Alan Macken; Ophelia Blake; Clodagh S O'Gorman
Journal:  Ir J Med Sci       Date:  2018-06-01       Impact factor: 1.568

2.  Facts and ideas from anywhere.

Authors:  William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-01

Review 3.  Cardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter.

Authors:  Holly C Gooding; Sarah D de Ferranti
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

Review 4.  Dyslipidemia in children with CKD: should we treat with statins?

Authors:  Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2011-04-13       Impact factor: 3.714

Review 5.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

6.  An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia.

Authors:  Kuan Gandelman; Paul Glue; Rachel Laskey; Jonathan Jones; Robert LaBadie; Leiv Ose
Journal:  Pediatr Cardiol       Date:  2011-01-23       Impact factor: 1.655

7.  Statin Use and the Risk of Type 2 Diabetes Mellitus in Children and Adolescents.

Authors:  Nina R Joyce; Justin P Zachariah; Charles B Eaton; Amal N Trivedi; Gregory A Wellenius
Journal:  Acad Pediatr       Date:  2017-02-21       Impact factor: 3.107

8.  Patterns and predictors of medication adherence to lipid-lowering therapy in children aged 8 to 20 years.

Authors:  Nina R Joyce; Gregory A Wellenius; Charles B Eaton; Amal N Trivedi; Justin P Zachariah
Journal:  J Clin Lipidol       Date:  2016-03-10       Impact factor: 4.766

Review 9.  Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.

Authors:  Anthony S Wierzbicki; Adie Viljoen
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 10.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.